LLY Stock: Unusual Options Activity Flags Both Upside and Downside Bets as Eli Lilly Trades Near $955
By TrendSpider Editor
Eli Lilly and Company is drawing attention in the options market today, with two unusual contracts totaling $2,525,000 in combined premium activity spotted on April 9, 2026. The stock is trading at $955.67, up 0.25% on the session, sitting in the middle of its 52-week range of $623.79 to $1,133.95.
LLY Stock: Unusual Options Activity Flags Both Upside and Downside Bets as Eli Lilly Trades Near $955
Eli Lilly and Company is drawing attention in the options market today, with two unusual contracts totaling $2,525,000 in combined premium activity spotted on April 9, 2026. The stock is trading at $955.67, up 0.25% on the session, sitting in the middle of its 52-week range of $623.79 to $1,133.95. The divergence between a near-term call and a longer-dated put suggests traders are positioning for meaningful price action in both directions over different time horizons.
Key Drivers of the LLY Stock Move
- Main Catalyst: Two unusual options contracts were flagged today carrying a combined premium of $2,525,000. A large call contract at the $1,050 strike expiring June 18, 2026 drew $1,980,000 in premium, while a put at the $890 strike expiring June 17, 2027 carried $545,000 in premium, pointing to bifurcated sentiment across different timeframes.
- Bull Case: The $1,050 call, representing the dominant portion of today's unusual premium at $1,980,000, targets a roughly 9.8% move above the current price of $955.67 and expires in just over two months. The contract size of 600 against an open interest percentage of 92% signals a significant and conviction-driven bet on a near-term rally.
- Bear Case: The $890 put expiring June 17, 2027 sits roughly 6.9% below current price levels and carries an open interest percentage of 238%, meaning today's activity dwarfs existing positioning in that contract. This outsized relative size suggests a deliberate longer-term hedge or directional bear bet, with $545,000 in premium committed to protect against a meaningful drawdown over the next 14 months.
The options setup reflects a market that is not fully decided on Eli Lilly's trajectory. The near-term call activity implies some traders expect a catalyst or continued momentum toward the upper half of the 52-week range, which peaked at $1,133.95. Meanwhile, the outsized open interest footprint on the long-dated put indicates someone is either protecting a large equity position or making a calculated bearish wager with a wide time horizon. Eli Lilly remains one of the most closely watched names in large-cap pharma, driven by sustained investor focus on its GLP-1 portfolio including tirzepatide, and any clinical, regulatory, or competitive developments in that space could serve as the catalyst that resolves this split positioning.
LLY Unusual Options Activity
- Contract 1: CALL | Strike: $1,050 | Expiry: June 18, 2026 | Volume: 600 | Open Interest: 92% | Premium: $1,980,000 | Status: Out of the Money
- Contract 2: PUT | Strike: $890 | Expiry: June 17, 2027 | Volume: 50 | Open Interest: 238% | Premium: $545,000 | Status: Out of the Money
Total unusual options premium today reached $2,525,000 across both contracts. The call side dominates in raw premium and contract size, while the put side stands out for its extraordinary open interest ratio, indicating today's volume is more than double the existing open interest in that specific contract.
LLY Seasonality
April and the early second quarter have historically been an active period for large-cap pharmaceutical names as the industry conference season ramps up and Q1 earnings results begin to surface. With the near-term call expiring in June, the timing aligns with a window that could capture any late spring clinical or earnings catalysts for Eli Lilly.
LLY Relative Performance
Eli Lilly's current price of $955.67 represents a gain of approximately 53% from the 52-week low of $623.79, though the stock remains roughly 15.7% below its 52-week high of $1,133.95. The modest 0.25% gain on today's session suggests the broader equity market's recovery from recent volatility is being reflected in LLY, though the stock has not reclaimed its peak levels from the past year, indicating that near-term upside conviction remains contested among market participants.